January 25, 2022 Acad, Gov/Utilities Licensing, IP, and Legal

Roche’s Evrysdi (risdiplam) granted FDA priority review for treatment of pre-symptomatic babies under 2 months of age with spinal muscular atrophy (SMA)

Interim data submitted to the FDA show majority of pre-symptomatic babies treated with Evrysdi for at least one year were able to sit, stand and walk within timeframes typical of healthy babies, as well as maintain swallowing Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated... Read more

January 11, 2022 Acad, Gov/Utilities M&A, Partnerships

Xylem and Isle Utilities Partner to Help Water Utilities Pilot and Scale Innovative Water Technology

New Funding Source for Trials of New Technologies That Reduce Carbon Emissions RYE BROOK, N.Y.–(BUSINESS WIRE)–Jan. 11, 2022– Global water technology leader, Xylem (NYSE:XYL), today announced it is sponsoring an innovative new funding mechanism for water utilities to deploy promising new technologies. The partnership with water consultancy Isle Utilities is a new approach to funding... Read more

January 7, 2022 Acad, Gov/Utilities Life Science Tools

Radboud University Medical Center Increases HiFi Sequencing Capacity with PacBio’s Sequel IIe

MENLO PARK, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced Radboud University Medical Center (Radboudumc) in Nijmegen, the Netherlands will increase their SMRT sequencing capacity with the addition of two new PacBio Sequel IIe Systems. Radboudumc has been using PacBio long-read technology... Read more

December 24, 2021 Acad, Gov/Utilities

Roche COVID-19 At-Home Test granted FDA Emergency Use Authorization to expand access to rapid self-testing solutions in the United States

Rapid test to support the American public’s fight against the COVID-19 pandemic, with availability to purchase over-the-counter (OTC) at pharmacies and retailers nationwide The COVID-19 At-Home Test uses a simple nasal swab sample to enable individuals to self-test at home and receive accurate, reliable and quick results in as few as 20 minutes for SARS-CoV-2... Read more

December 9, 2021 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Life Science Tools

FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue

FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue CARLSBAD, Calif., Dec. 9, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to help identify non-small cell lung cancer (NSCLC) patients... Read more

November 29, 2021 Acad, Gov/Utilities Clinical Research/Diagn. M&A, Partnerships

Cancer Patients may get Faster and more Personalized Treatment as result of Collaboration between GE Healthcare, University of Cambridge and Addenbrooke’s hospital

Teams plan to cooperate on the development of a machine learning-based solution, aiming to improve care for cancer patients by giving cancer care teams access to complex data and information The potentially transformative solution will initially focus on ovarian cancer and will then expand for use in breast and kidney cancer.  Cambridge/Chalfont St Giles, UK;... Read more